lauseker@ibe.med.uni-muenchen.de2001 Abitur
2001 - 2007 Studium der Statistik an der LMU München (Anwendungsgebiet: Biologie)
Seit August 2007 Wissenschaftlicher Mitarbeiter am IBE
"LIFESTAT 2008 – Statistics and Life Sciences": 54. Biometrisches Kolloquium/ First Conference of the Central European Network, München, 10. -11. März 2008. Abstract, Vortrag und Poster: Lauseker M, Pfirrmann M. Turnbull's nonparametric estimator and its application to the analysis of failure and suboptimal response in chronic myeloid leukaemia (CML).
29th Annual Conference of the International Society for Clinical Biostatistics, Kopenhagen, 17 - 21 August 2008. Abstract und Poster: Lauseker M, Pfirrmann M. Turnbull's nonparametric estimator for interval-censored data in the case of informative censoring - a simulation study.
53. gmds-Jahrestagung, Stuttgart, 15.-19. September 2008. Abstract und Poster: Lauseker M, Pfirrmann M. Turnbulls nichtparametrischer Schätzer für intervallzensierte Daten im Falle informativer Zensierung - eine Simulationsstudie.
30th Annual Conference of the International Society for Clinical Biostatistics, Prag, 23 - 27 August 2009. Vortrag: Lauseker M, Hasford J, Hochhaus, A. Prediction in multi-state models and its application in chronic myeloid leukaemia.
54. gmds-Jahrestagung, Essen, 07.-10. September 2009. Vortrag: Lauseker M, Hasford J, Hochhaus, A. Vorhersage bei Multistate-Modellen und die Anwendung in der chronisch myeloischen Leukämie.
Second joint statistical meeting Deutsche Arbeitsgemeinschaft Statistik / 56. Biometrisches Kolloquium, Dortmund, 23.-26. März 2010. Vortrag: Lauseker M, Hasford J, Hochhaus, A. Prediction in multi-state models and its application in chronic myeloid leukaemia.
31st Annual ISCB Conference of the International Society for Clinical Biostatistics, Montpellier, 29 August - 02 September 2010. Abstract und Poster: Lauseker M, Germing U, Kelaidi C, Hasford J. Comparison of three approaches of modelling cause-specific hazards in the context of myelodysplastic syndrome
32nd Annual ISCB Conference of the International Society for Clinical Biostatistics, Ottawa, 21 - 25 August 2011. Abstract und Poster: Lauseker M. Dependent left truncation in Geskus’ model for the subdistribution hazard of a competing risk – a simulation study
Hehlmann R, Lauseker M, Jung-Munkwitz S, Leitner A, Müller MC, Pletsch N, Proetel U, Haferlach C, Schlegelberger B, Balleisen L, Hänel M, Pfirrmann M, Krause SW, Nerl C, Pralle H, Gratwohl A, Hossfeld DK, Hasford J, Hochhaus A, Saussele S.
Tolerability-adapted imatinib 800 mg/d versus 400 mg/d versus 400 mg/d plus interferon-α in newly diagnosed chronic myeloid leukemia.
J Clin Oncol. 2011 Apr 20;29(12):
Pfirrmann M, Hochhaus A, Lauseker M, Saußele S, Hehlmann R, Hasford J.
Recommendations to meet statistical challenges arising from endpoints beyond overall survival in clinical trials on chronic myeloid leukemia.
Leukemia. 2011 Sep;25(9):1433-1438.
Fabarius A, Leitner A, Hochhaus A, Müller MC, Hanfstein B, Haferlach C, Göhring G, Schlegelberger B, Jotterand M, Reiter A, Jung-Munkwitz S, Proetel U, Schwaab J, Hofmann WK, Schubert J, Einsele H, Ho AD, Falge C, Kanz L, Neubauer A, Kneba M, Stegelmann F, Pfreundschuh M, Waller CF, Spiekermann K, Baerlocher GM, Lauseker M, Pfirrmann M, Hasford J, Saussele S, Hehlmann R.
Impact of ACA at diagnosis on prognosis of CML: long-term observation from 1151 patients of the randomized CML Study IV.
Blood. 2011 Oct 28. [Epub ahead of print]
Germing U, Lauseker M, Hildebrandt B, Symeonidis A, Cermak J, Fenaux P, Kelaidi C, Pfeilstöcker M, Nösslinger T, Sekeres M, Maciejewski J, Haase D, Schanz J, Seymour J, Kenealy M, Weide R, Lübbert M, Platzbecker U, Valent P, Götze K, Stauder R, Blum S, Kreuzer K-A, Schlenk R, Ganser A, Hofmann W-K, Aul C, Krieger O, Kündgen A, Haas R, Hasford J, Giagounidis A.
Survival, Prognostic Factors, and Rates of Leukemic Transformation in 381 Untreated Patients with MDS and del(5q): A Multicenter Study
Leukemia, accepted for publication
RSS